Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “biliary tract”
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
ClinicalTrials.gov study NCT00532441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
ClinicalTrials.gov study NCT04466891. IPD Sharing: YES. Countries: 9. Publications: 2.
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04163900. IPD Sharing: NO. Countries: 15. Publications: 2.
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
ClinicalTrials.gov study NCT02821754. IPD Sharing: YES. Countries: 1. Publications: 5.
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
ClinicalTrials.gov study NCT03875235. IPD Sharing: YES. Countries: 17. Publications: 5.
Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy
ClinicalTrials.gov study NCT02579616. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
ClinicalTrials.gov study NCT00948935. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
ClinicalTrials.gov study NCT02443324. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
ClinicalTrials.gov study NCT04057365. IPD Sharing: YES. Countries: 1. Publications: 0.
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
ClinicalTrials.gov study NCT07156058. IPD Sharing: Not stated. Countries: 1. Publications: 25.
Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody
ClinicalTrials.gov study NCT05994001. IPD Sharing: NO. Countries: 1. Publications: 2.
CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
ClinicalTrials.gov study NCT02094560. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
ClinicalTrials.gov study NCT01297998. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02146703. IPD Sharing: Not stated. Countries: 1. Publications: 12.
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01242605. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
ClinicalTrials.gov study NCT05512377. IPD Sharing: YES. Countries: 16. Publications: 1.
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
ClinicalTrials.gov study NCT05506943. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07159217. IPD Sharing: NO. Countries: 1. Publications: 1.
Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02386397. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT00939848. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.